AnGes filed for approval of its HGF gene therapy product Collategene® for the first time since the introduction of the conditional/time-limited authorization system for regenerative medicine products

Mitsubishi Tanabe Pharma Corporation, a member of the Mitsubishi Chemical Group, has announced the following press release.

■Mitsubishi Tanabe Pharma　Press Release
AnGes filed for approval of its HGF gene therapy product Collategene® for the first time since the introduction of the conditional/time-limited authorization system for regenerative medicine products
https://www.mt-pharma.co.jp/e/news/assets/pdf/e_MTPC230531.pdf